Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Sergey Yurasov
Person

Sergey Yurasov

Tracked across 1 events · 6 articles · First seen May 21, 2026 · Last active May 21, 2026

Sentiment
50
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 50
Business
Black Diamond Therapeutics' Silevertinib Phase 2 Success
Impact: Sergey Yurasov, Chief Medical Officer of Black Diamond Therapeutics, expressed optimism about Silevertinib's potential to be a practice-changing therapy.
May 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sergey Yurasov live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.